All In Biotech

Drug Trial Radar · NCT06635148

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 274 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

274

Planned (sponsor's estimate)

Start

Sep 19, 2024

Primary completion

Aug 24, 2029

Study completion Jul 16, 2030

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Oct 10, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.

Conditions

  • Geographic Atrophy
  • Macular Degeneration

Interventions

  • JNJ-81201887Drug

    No study intervention will be administered as part of this LTE study.

  • Sham ProcedureOther

    No study intervention will be administered as part of this LTE study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Ocular and Systemic Treatment-emergent Adverse Events (TEAEs)Time frame: Upto 5 Years
  2. Number of Participants with Abnormal Findings in Clinical Laboratory AssessmentsTime frame: Upto 5 Years
  3. Number of Participants with Abnormal Findings in Retinal imaging and Eye ExaminationsTime frame: Upto 5 Years
  4. Change from Baseline in Best Corrected Visual Acuity (BCVA) Using Early Treatment Diabetic Retinopathy Study (ETDRS) Letter ScoreTime frame: Baseline up to 42 months

Locations

104 sites in 18 countries. Site status is shown where the registry gives one.

  • Retina Associates Southwest PC

    Tucson, Arizona · Recruiting

  • Retina Consultants of Orange County

    Fullerton, California · Recruiting

  • Shiley Eye Institute Jacobs Retina Center

    La Jolla, California · Recruiting

  • California Retina Consultants

    Oxnard, California · Recruiting

  • California Eye Medical Specialists

    Pasadena, California · Recruiting

  • Retina Consultants San Diego

    Poway, California · Recruiting

  • Bay Area Retina Associates

    Walnut Creek, California · Recruiting

  • Retina Group of Florida

    Fort Lauderdale, Florida · Recruiting

  • VitreoRetinal Associates, PA

    Gainesville, Florida · Recruiting

  • Retina Specialty Institute

    Pensacola, Florida · Recruiting

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida · Recruiting

  • Georgia Retina

    Marietta, Georgia · Recruiting

  • Marietta Eye Clinic

    Marietta, Georgia · Recruiting

  • University Retina

    Lemont, Illinois · Recruiting

  • Midwest Eye Institute

    Carmel, Indiana · Recruiting

  • Maine Eye Center

    Portland, Maine · Recruiting

  • Retina Specialists

    Baltimore, Maryland · Recruiting

  • The Retina Group of Washington

    Chevy Chase, Maryland · Recruiting

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland · Recruiting

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts · Recruiting

  • Foundation for Vision Research

    Grand Rapids, Michigan · Recruiting

  • Retina Consultants of Minnesota

    Saint Louis Park, Minnesota · Recruiting

  • The Retina Institute

    St Louis, Missouri · Recruiting

  • Sierra Eye Associates

    Reno, Nevada · Recruiting

  • Retina-Vitreous Surgeons of Central New York

    Liverpool, New York · Recruiting

  • Asheville Eye Associates - Western Carolina Retinal Associates

    Asheville, North Carolina · Recruiting

  • Duke Eye Center

    Durham, North Carolina · Recruiting

  • Graystone Eye

    Hickory, North Carolina · Recruiting

  • NC Retina Associates

    Wake Forest, North Carolina · Recruiting

  • Cincinnati Eye Institute

    Cincinnati, Ohio · Recruiting

  • Cleveland Clinic Main Campus

    Cleveland, Ohio · Recruiting

  • Verum Research LLC

    Eugene, Oregon · Recruiting

  • Cascade Medical Research Institute, LLC

    Springfield, Oregon · Recruiting

  • Erie Retina Research

    Erie, Pennsylvania · Recruiting

  • Charleston Neuroscience Institute, LLC

    Beaufort, South Carolina · Recruiting

  • Austin Clinical Research

    Austin, Texas · Recruiting

  • Texas Retina Associates

    Dallas, Texas · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Retina Associates Of South Texas P A

    San Antonio, Texas · Recruiting

  • Retina Consultants of Texas

    The Woodlands, Texas · Recruiting

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.